title: American Society of Peritoneal Surface Malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer.
authors.affiliation: Department of Surgical Oncology, Cancer Treatment Centers of America, Philadelphia, Pennsylvania.
authors.forename: Jesus
authors.initials: J
authors.lastname: Esquivel
authors.forename: Pompiliu
authors.initials: P
authors.lastname: Piso
authors.forename: Vic
authors.initials: V
authors.lastname: Verwaal
authors.forename: Thomas
authors.initials: T
authors.lastname: Bachleitner-Hofmann
authors.forename: Olivier
authors.initials: O
authors.lastname: Glehen
authors.forename: Santiago
authors.initials: S
authors.lastname: González-Moreno
authors.forename: Marcello
authors.initials: M
authors.lastname: Deraco
authors.forename: Joerg
authors.initials: J
authors.lastname: Pelz
authors.forename: Richard
authors.initials: R
authors.lastname: Alexander
authors.forename: Gabriel
authors.initials: G
authors.lastname: Glockzin
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D010478:Chemotherapy, Cancer, Regional Perfusion; D015179:Colorectal Neoplasms / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D013505:Digestive System Surgical Procedures; D005104:Expert Testimony; D006801:Humans; D006979:Hyperthermia, Induced; D010534:Peritoneal Neoplasms / Q000473:pathology / Q000628:therapy*; D011379:Prognosis; D012958:Societies, Scientific